These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1347 related articles for article (PubMed ID: 20092558)
1. Genetic reductions of beta-site amyloid precursor protein-cleaving enzyme 1 and amyloid-beta ameliorate impairment of conditioned taste aversion memory in 5XFAD Alzheimer's disease model mice. Devi L; Ohno M Eur J Neurosci; 2010 Jan; 31(1):110-8. PubMed ID: 20092558 [TBL] [Abstract][Full Text] [Related]
2. Partial reduction of BACE1 improves synaptic plasticity, recent and remote memories in Alzheimer's disease transgenic mice. Kimura R; Devi L; Ohno M J Neurochem; 2010 Apr; 113(1):248-61. PubMed ID: 20089133 [TBL] [Abstract][Full Text] [Related]
3. A combination Alzheimer's therapy targeting BACE1 and neprilysin in 5XFAD transgenic mice. Devi L; Ohno M Mol Brain; 2015 Mar; 8():19. PubMed ID: 25884928 [TBL] [Abstract][Full Text] [Related]
4. Effects of BACE1 haploinsufficiency on APP processing and Aβ concentrations in male and female 5XFAD Alzheimer mice at different disease stages. Devi L; Ohno M Neuroscience; 2015 Oct; 307():128-37. PubMed ID: 26314636 [TBL] [Abstract][Full Text] [Related]
5. Mechanisms that lessen benefits of β-secretase reduction in a mouse model of Alzheimer's disease. Devi L; Ohno M Transl Psychiatry; 2013 Jul; 3(7):e284. PubMed ID: 23880880 [TBL] [Abstract][Full Text] [Related]
6. Phospho-eIF2α level is important for determining abilities of BACE1 reduction to rescue cholinergic neurodegeneration and memory defects in 5XFAD mice. Devi L; Ohno M PLoS One; 2010 Sep; 5(9):e12974. PubMed ID: 20886088 [TBL] [Abstract][Full Text] [Related]
7. 1950 MHz Electromagnetic Fields Ameliorate Aβ Pathology in Alzheimer's Disease Mice. Jeong YJ; Kang GY; Kwon JH; Choi HD; Pack JK; Kim N; Lee YS; Lee HJ Curr Alzheimer Res; 2015; 12(5):481-92. PubMed ID: 26017559 [TBL] [Abstract][Full Text] [Related]
8. Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1. Ohno M; Chang L; Tseng W; Oakley H; Citron M; Klein WL; Vassar R; Disterhoft JF Eur J Neurosci; 2006 Jan; 23(1):251-60. PubMed ID: 16420434 [TBL] [Abstract][Full Text] [Related]
9. 7,8-dihydroxyflavone, a small-molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease. Devi L; Ohno M Neuropsychopharmacology; 2012 Jan; 37(2):434-44. PubMed ID: 21900882 [TBL] [Abstract][Full Text] [Related]
10. Beta-secretase-1 elevation in transgenic mouse models of Alzheimer's disease is associated with synaptic/axonal pathology and amyloidogenesis: implications for neuritic plaque development. Zhang XM; Cai Y; Xiong K; Cai H; Luo XG; Feng JC; Clough RW; Struble RG; Patrylo PR; Yan XX Eur J Neurosci; 2009 Dec; 30(12):2271-83. PubMed ID: 20092570 [TBL] [Abstract][Full Text] [Related]
11. Berberine Alleviates Amyloid-Beta Pathology in the Brain of APP/PS1 Transgenic Mice via Inhibiting β/γ-Secretases Activity and Enhancing α-Secretases. Cai Z; Wang C; He W; Chen Y Curr Alzheimer Res; 2018; 15(11):1045-1052. PubMed ID: 29962345 [TBL] [Abstract][Full Text] [Related]
12. Aβ reduction in BACE1 heterozygous null 5XFAD mice is associated with transgenic APP level. Sadleir KR; Eimer WA; Cole SL; Vassar R Mol Neurodegener; 2015 Jan; 10():1. PubMed ID: 25567526 [TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of the β-secretase inhibitor GRL-8234 in 5XFAD Alzheimer's transgenic mice lessen during disease progression. Devi L; Tang J; Ohno M Curr Alzheimer Res; 2015; 12(1):13-21. PubMed ID: 25523425 [TBL] [Abstract][Full Text] [Related]
14. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis. Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065 [TBL] [Abstract][Full Text] [Related]
15. Mitochondrial dysfunction and accumulation of the β-secretase-cleaved C-terminal fragment of APP in Alzheimer's disease transgenic mice. Devi L; Ohno M Neurobiol Dis; 2012 Jan; 45(1):417-24. PubMed ID: 21933711 [TBL] [Abstract][Full Text] [Related]
16. Sex- and brain region-specific acceleration of β-amyloidogenesis following behavioral stress in a mouse model of Alzheimer's disease. Devi L; Alldred MJ; Ginsberg SD; Ohno M Mol Brain; 2010 Nov; 3():34. PubMed ID: 21059265 [TBL] [Abstract][Full Text] [Related]
17. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease. Hüttenrauch M; Baches S; Gerth J; Bayer TA; Weggen S; Wirths O J Alzheimers Dis; 2015; 44(4):1291-302. PubMed ID: 25408216 [TBL] [Abstract][Full Text] [Related]
18. Knock-in of human BACE1 cleaves murine APP and reiterates Alzheimer-like phenotypes. Plucińska K; Crouch B; Koss D; Robinson L; Siebrecht M; Riedel G; Platt B J Neurosci; 2014 Aug; 34(32):10710-28. PubMed ID: 25100603 [TBL] [Abstract][Full Text] [Related]
19. Mechanisms underlying insulin deficiency-induced acceleration of β-amyloidosis in a mouse model of Alzheimer's disease. Devi L; Alldred MJ; Ginsberg SD; Ohno M PLoS One; 2012; 7(3):e32792. PubMed ID: 22403710 [TBL] [Abstract][Full Text] [Related]
20. Alternative Selection of β-Site APP-Cleaving Enzyme 1 (BACE1) Cleavage Sites in Amyloid β-Protein Precursor (APP) Harboring Protective and Pathogenic Mutations within the Aβ Sequence. Kimura A; Hata S; Suzuki T J Biol Chem; 2016 Nov; 291(46):24041-24053. PubMed ID: 27687728 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]